Below are the most recent publications written about "Endothelial Cells" by people in Profiles.
-
Asante J, Barger SW. Impact of P-glycoprotein substrates on transendothelial transport of amyloid-? peptide in an in vitro model. Neuroscience. 2026 May 14; 602:104-111.
-
Irei JS, Hirayama K, Boisvert WA. Emerging regulators of endothelial lipid metabolism in atherosclerosis. Curr Opin Lipidol. 2026 Jun 01; 37(3):113-119.
-
Salian VS, Curan GL, Lowe VJ, Tang X, Kalari KR, Kandimalla KK. Elucidating molecular mechanisms governing tumor necrosis factor-alpha-mediated regulation of amyloid beta 42 uptake in blood-brain barrier endothelial cells. Mol Pharmacol. 2026 Jan; 108(1):100088.
-
Bai Y, Ren H, Leng S, Yuan M, Jiang Y, Zhang S, Wang Y, Ju M, Wang Z, Xi W, Xu L, Zheng B, Li D, Huo X, Zhu T, Zhang B, Shen L, Zhang Y, Jiang W, Zhang JH, Han B, Yao H. CD8+GZMK+CD27+CCR7+ T cells mobilized by splenic sympathetic nerves aggravate brain ischemia?reperfusion injury via CCL19-positive endothelial cells. Cell Mol Immunol. 2025 Sep; 22(9):1061-1076.
-
Wahab R, Keshavarz A, Azam Z, Islam T, Hasan MM, Zhang X, Alobaida A, Rana M, Choi JU, Alam F, Kim IS, Byun Y, McCarty JH, Nickel NP, Roy S, Al-Hilal TA. Microfluidic captured patient-derived circulating endothelial cells identify novel targets of pulmonary arterial hypertension. Biomaterials. 2025 Dec; 323:123429.
-
Wang L, Curran GL, Zhong R, Xue Z, Veerareddy V, Thieschafer J, Min PH, Li L, Lowe VJ, Kandimalla KK. Amyloid beta peptides inhibit glucose transport at the blood-brain barrier by disrupting the insulin-AKT pathway. J Cereb Blood Flow Metab. 2025 Oct; 45(10):1961-1979.
-
Cai Z, Zhang Y, He L, Cui M, Zhang W, E L, Yang H, Ling Q, Hoffmann PR, He J, Gou S, Liu F, Huang Z. Methylseleninic Acid Elevating the Nrf2-GPX4 Axis Relieves Endothelial Dysfunction and Ferroptosis Induced by Arsenic Exposure. J Agric Food Chem. 2025 Mar 26; 73(12):7445-7455.
-
Ferrini MG, Abraham A, Mill?n R, Graciano L, Eleswarapu SV, Rajfer J. Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway. PLoS One. 2025; 20(2):e0316798.
-
Salian VS, Tang X, Thompson KJ, Curan GL, Lowe VJ, Li L, Kalari KR, Kandimalla KK. Molecular Mechanisms Underlying Amyloid Beta Peptide Mediated Upregulation of Vascular Cell Adhesion Molecule-1 in Alzheimer Disease. J Pharmacol Exp Ther. 2024 Nov 19; 391(3):430-440.
-
Wang Z, Zhong R, Curran GL, Min P, Lowe VJ, Li L, Kandimalla KK. High-Density Lipoprotein Mimetic Peptide 4F Reduces Toxic Amyloid-Beta Exposure to the Blood-Brain Barrier Endothelium in Alzheimer's Disease Transgenic Mice. Mol Pharm. 2024 Nov 04; 21(11):5661-5671.